Neurotransmitters act as chemical messengers that are released from neurons in order to communicate with other cells. These neurotransmitters can activate several signaling pathways within the body that ultimately lead to a variety of cellular responses. Essentially, the release of neurotransmitters serves as an intercellular communication mechanism between neurons and other cells. Neurons produce several types of neurotransmitters, all of which can act on cell surface receptors that are specific to a particular type of neurotransmitter. Once the receptor detects a neurotransmitter, it triggers a chain of events inside the cell known as signal transduction, which involves relaying the message from the neurotransmitter to the target cell. Some of the most widely studied neurotransmitters include acetylcholine, norepinephrine, serotonin and dopamine. Signaling can be thought of as a highly-orchestrated collaboration between neurons and other cells in order to relay information within the body. For example, when dopamine is released from a neuron it binds to specific receptors on the surface of another cell that then activates other mechanisms within the cell that can alter the cell’s behavior. This communication network is essential for normal physiological function, especially in the brain and the nervous system. The neurotransmitters and their respective receptors are exquisitely regulated, and the existence of defects in neurotransmitter systems can lead to numerous medical conditions, such as depression, Parkinson’s disease, and Alzheimer’s disease. Many drugs on the market today are designed to target specific neurotransmitters, such as selective serotonin re-uptake inhibitors (SSRI), which are commonly used to treat depression. By understanding the physiological mechanisms surrounding neurotransmitter release, scientists can continue to uncover new treatments for neuropsychiatric disorders.
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : ADNP regulates cortical development: Mechanism of ADNP syndrome/autism
Kazuhito Toyooka, Drexel University College of Medicine, United States
Title : Mild cognitive impairment (MCI) in Parkinson’s disease: Prevalence given MDS criteria
Cay Anderson Hanley, iPACES, United States
Title : Modeling early neurologic trajectories after elevated leg positioning (ELP): A secondary analysis of the LEG-UP randomized feasibility study
Kayode Ahmed, The University of Texas MD Anderson Cancer Center, United States
Title : Neuro-exergaming for non-verbal autism spectrum: A case study of neuropsychological function after 15 sessions of pedal-n-play iPACES
Cay Anderson Hanley, iPACES, United States
Title : Prescribing joy: The importance of integrating memory cafes into dementia care
Saul Beaumont, Massachusetts Advisory Council on Alzheimer's Disease and All Other Dementias, United States